Gene therapy preparations manufacturing · Massachusetts

Shire: Alewife

Cambridge, MA · ~281 workers · 3 years of OSHA Injury Tracking Application data.

B
Good Safety Record
2.0
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Shire: Alewife runs at 60% of its industry's injury rate - safer than the typical Gene therapy preparations manufacturing workplace, earning a grade B.

Shire: Alewife: 2.0 TCR = 60% of Gene therapy preparations manufacturing BLS 3.3 · 3y Form 300A (see methodology below)

Shire: Alewife safety composite

Shire: Alewife scores strongest on fatalities (safer than 50% of same-industry peers) and weakest on dart rate (safer than 14%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

F

28/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
F 1.99 per 100 workers

Safer than 27% of industry peers

DART rate
F 2.01 per 100 workers

Safer than 14% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

Rising injury rate

Shire: Alewife: 2.4 → 2.8 TCR

Peak year 2018 @ 2.8 TCR · DART/TCR 1.01× in 2018

Shire: Alewife's TCR rose 0.4 from 2.4 in 2016 to 2.8 in 2018. In 2018, DART was 1.01× this establishment's average TCR (severity share of cases).

OSHA ITA Form 300A scorecard

Establishment book 325414 · Cambridge, MA AT/BELOW-IND · MID

Grade B · TCR 2.0 · 60% of ind

  • DART 2.0 DART
  • RANK #34/37
  • PHOTO Novartis Pharmaceuti…
  • BOOK 3y book
  • INJ 15 inj
  • SIZE ~281 FTE

Nearest TCR peer: Novartis Pharmaceuticals (0.0 TCR gap)

Read with this employer → · Industry book → · Massachusetts employers → · Look up another →

Shire: Alewife in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Shire: Alewife averages 2.0 TCR (60% of the Gene therapy preparations manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Shire: Alewife TCR series: 2016=2.4 · 2017=0.7 · 2018=2.8 · BLS 3.3

Where Shire: Alewife falls in its industry

234 Gene therapy preparations manu establishments

Safer than 27% of graded establishments in this industry, whose median TCR is 1.2.

More dangerous than peersSafer than peers

Narrower to Massachusetts alone (the establishments it most directly competes with for workers and contracts): ranked #34 safest of 37 Gene therapy preparations manu employers in Massachusetts.

Shire: Alewife (281 employees, TCR 2.0) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 05001,0001,5002,000 0246 Average employees Total Case Rate Shire: Alewife
Shire: Alewife (281 employees, TCR 2.0) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2

Shire: Alewife has more employees than the Gene therapy preparations manufacturing median and a higher injury rate than the industry's median TCR of 1.2. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2018 2.8 2.0 6 1 0
2017 0.7 0.7 2 0 0
2016 2.4 2.1 7 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

325414 · MA · Cambridge

234 Gene therapy preparations manufacturing employers nationwide with a credible TCR · 10,108 rated employers in Massachusetts with headcount on file · 149 employers in Cambridge, MA · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Novartis Pharmaceuticals 2.0 TCR
NAICS-TCR Smith & Nephew Columbia MD 2.0 TCR
NAICS-TCR Elanco Maine Winslow 2.0 TCR
NAICS-TCR Shire - Milford MA 2.0 TCR
STATE-SIZE Greenwood Industries 281 FTE
STATE-SIZE ADESA : Boston 281 FTE
STATE-SIZE Amazon.com Services LLC - DMH9 281 FTE
STATE-SIZE 2576-40010000-4001 281 FTE
CITY-NEAR Philips NAM Field Sales & Service 5,136 FTE
CITY-NEAR Vinfen Corporation 2,662 FTE
CITY-NEAR Biogen - Cambridge 2,478 FTE
CITY-NEAR Cambridge Campus 2,473 FTE
NAT-TCR WVUH Student Health and Urgent Care 2.0 TCR
NAT-TCR Elkhart Brass Manufacturing Company, Inc. 2.0 TCR
NAT-TCR Sea Ray Merritt Island Complex 2.0 TCR
NAT-TCR Amcoer Allentown 2.0 TCR
NAT-SIZE LaShip LLC 281 FTE
NAT-SIZE Coremark Denver 281 FTE
NAT-SIZE 3495-11D9987 281 FTE
NAT-SIZE Holland - CH 281 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2018, 2017, 2016. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.